[Experimental study of the pharmacodynamic effects of a camphosulfonic derivative of nicotinoyl dimethyl pyrazolone].
D000700:Analgesics / Q000494:pharmacology; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D001835:Body Weight / Q000187:drug effects; D004804:Eosinophils / Q000187:drug effects; D006321:Heart / Q000187:drug effects; D007668:Kidney / Q000187:drug effects; D008099:Liver / Q000187:drug effects; D009539:Nicotinic Acids / Q000494:pharmacology*; D009929:Organ Size; D010653:Phenylbutazone / Q000494:pharmacology; D011720:Pyrazoles / Q000494:pharmacology*; D051381:Rats; D012216:Rheumatic Diseases / Q000188:drug therapy*; D013154:Spleen / Q000187:drug effects; D013276:Stomach Ulcer / Q000139:chemically induced; D013729:Terpenes / Q000494:pharmacology*
D000700:Analgesics; D000893:Anti-Inflammatory Agents; D009539:Nicotinic Acids; D011720:Pyrazoles; D013729:Terpenes; D010653:Phenylbutazone
Etude expérimentale à propos des effets pharmacodynamiques d'un dérivé camphousulfonique de la nicotinoly diméthyl pyrazolone.